The focus on technology as a driver of performance improvement in clinical trials is intense, but despite years of valiant efforts, study execution remains far from optimal. For study startup, the data are dismal.
What exactly do terms like remote, site-less, hybrid, and decentralized trials mean and do for us? In order to work together, we need to better understand each other and what terms help and hinder our progress.
Sponsors primarily outsource to CROs to control operational and infrastructure costs. Although there are obvious benefits to outsourcing, it creates new challenges around quality, oversight, collaboration, and governance.
As organizations reach their digitization goals, they now are facing new challenges. Current healthcare systems are generally adequate at answering specific questions for end-users by may be limited in addressing more complex questions.